Skip to main content

Prestige Consumer Healthcare Inc.

corporate_fare Company Profile

Prestige Consumer Healthcare Inc.

PBH·NYSE·Healthcare·CIK 0001295947

Prestige Consumer Healthcare Inc. develops, manufactures, markets, sells, and distributes well-recognized, brand-name, over-the-counter (OTC) health and personal care products. The company was formed as a Delaware corporation in 1996 and was previously named Prestige Brands Holdings, Inc. until August 17, 2018. Prestige sells its products to mass merchandisers, drug/drug wholesale, food, dollar, convenience, and club stores, as well as e-commerce channels. Its operations are divided into two reportable segments: North American OTC Healthcare and International OTC Healthcare. Geographically, the company operates in North America (the United States and Canada), Australia, and certain other international markets. Prestige grows its product portfolio through both organic development, including new product lines and brand extensions, and acquisitions of consumer health and personal care brands.

Prestige Consumer Healthcare Inc. (NYSE:PBH) is a publicly traded company in the Healthcare sector. Wiseek monitors PBH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Prestige Consumer Healthcare Reports FY26 Revenue & EPS Decline, Announces $150M Acquisition, Boosts Share Buybacks
  • Prestige Consumer Healthcare Acquires LaCorium Health for $150M, Reports FY26 Results & Positive FY27 Outlook
  • Prestige Consumer Healthcare Reports Fiscal 2026 Results, Acquires LaCorium Health
  • Prestige Consumer Healthcare to Acquire Breathe Right and Other Brands for $1.045 Billion, Boosting Portfolio and Revenue
  • Prestige Consumer Healthcare Reports Q3 Earnings Decline Amid Strategic Acquisitions and Share Buybacks

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$1.09B
Net Income
$190.3M
Diluted EPS
$3.91
Op. Cash Flow
$257.63M
Free Cash Flow
$246.45M
Gross Profit
$595.58M
Operating Income
$309.41M
Cash & Equivalents
$63.87M
Total Debt
$993.95M
Debt / Equity
0.53×
Net Margin
17.5%
Shares Outstanding
48.46M sh
Source: 10-K · filed 2026-05-14 · accession 0001295947-26-000016
Browse all tickers starting with P →
$47.82
52-week range · as of 2026-05-14 $42.62 – $89.37
Market cap
$2.27B
Volume
543.2K (0.7× avg)
3-mo avg 784K
Live data · 2026-06-14 03:53 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PBH - Latest Insights

PBH
May 14, 2026, 4:32 PM EDT
Filing Type: 10-K
Importance Score:
8
Prestige Consumer Healthcare Reports FY26 Revenue & EPS Decline, Announces $150M Acquisition, Boosts Share Buybacks
Price at Filing: $45.93
Real-time Price: $47.82 info
Change: +$1.89 (+4%) info
Market Cap: $2.265B info
Sentiment: Neutral
View Wiseek Article
PBH
May 13, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8
Prestige Consumer Healthcare Acquires LaCorium Health for $150M, Reports FY26 Results & Positive FY27 Outlook
Price at Filing: $51.81
Real-time Price: $47.82 info
Change: -$3.99 (-8%) info
Market Cap: $2.265B info
Sentiment: Positive
View Wiseek Article
PBH
May 13, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Prestige Consumer Healthcare Reports Fiscal 2026 Results, Acquires LaCorium Health
Price at Filing: $51.81
Real-time Price: $47.82 info
Change: -$3.99 (-8%) info
Market Cap: $2.265B info
Sentiment: Neutral
View Wiseek Article
PBH
Mar 20, 2026, 6:15 AM EDT
Filing Type: 8-K
Importance Score:
9
Prestige Consumer Healthcare to Acquire Breathe Right and Other Brands for $1.045 Billion, Boosting Portfolio and Revenue
Price at Filing: $60.06
Real-time Price: $47.82 info
Change: -$12.24 (-20%) info
Market Cap: $2.265B info
Sentiment: Positive
View Wiseek Article
PBH
Feb 05, 2026, 6:09 AM EST
Filing Type: 10-Q
Importance Score:
7
Prestige Consumer Healthcare Reports Q3 Earnings Decline Amid Strategic Acquisitions and Share Buybacks
Price at Filing: $67.03
Real-time Price: $47.82 info
Change: -$19.21 (-29%) info
Market Cap: $2.265B info
Sentiment: Negative
View Wiseek Article
PBH
Feb 05, 2026, 6:04 AM EST
Filing Type: 8-K
Importance Score:
7
Prestige Consumer Healthcare Reports Q3 Results, Narrows FY26 Revenue & EPS Outlook
Price at Filing: $67.03
Real-time Price: $47.82 info
Change: -$19.21 (-29%) info
Market Cap: $2.265B info
Sentiment: Neutral
View Wiseek Article